e-learning
resources
Munich 2006
Tuesday 05.09.2006
COPD therapy
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Salmeterol/fluticasone propionate (SFC) improves the inspiratory to total lung capacity ratio (IC/TLC) and exercise endurance time in patients with COPD
B. Celli, A. Emmett, G. Crater, C. Kalberg (Boston, Research Triangle Park, United States Of America)
Source:
Annual Congress 2006 - COPD therapy
Session:
COPD therapy
Session type:
Oral Presentation
Number:
4395
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
B. Celli, A. Emmett, G. Crater, C. Kalberg (Boston, Research Triangle Park, United States Of America). Salmeterol/fluticasone propionate (SFC) improves the inspiratory to total lung capacity ratio (IC/TLC) and exercise endurance time in patients with COPD. Eur Respir J 2006; 28: Suppl. 50, 4395
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Middle-long term pulmonary abnormalities after severe COVID-19 pneumonia which required invasive ventilation
Related content which might interest you:
Effect of salmeterol on the ventilatory response to exercise in chronic obstructive pulmonary disease
Source: Eur Respir J 2004; 24: 86-94
Year: 2004
Effect of umeclidinium/vilanterol (UMEC/VI) on inspiratory capacity/total lung capacity ratio in hyperinflated COPD patients
Source: International Congress 2015 – New data on established treatments for COPD
Year: 2015
Inspiratory fraction and exercise impairment in COPD patients GOLD stages II-III
Source: Eur Respir J 2006; 28: 939-944
Year: 2006
Endurance shuttle walking test: responsiveness to salmeterol in COPD
Source: Eur Respir J 2008; 31: 579-584
Year: 2008
Exercise and dyspnoea in COPD
Source: Eur Respir Rev 2006; 15: 72-79
Year: 2006
Mechanisms limiting exercise in COPD: new insights
Source: Annual Congress 2005 - Mechanical factors limiting physical exercise in disease
Year: 2005
The effect of non-invasive ventilation (NIV) during exercise on inspiratory capacity (IC) and endurance time (Tlim) in patients with severe COPD
Source: International Congress 2019 – Oxygen supplementation, noninvasive ventilation and mobility aspects of patients with impaired respiration
Year: 2019
Does dynamic hyperinflation contribute to dyspnoea during exercise in patients with COPD?
Source: Eur Respir J 2012; 40: 322-329
Year: 2012
Inspiratory capacity (IC) and dyspnea during recovery from symptom-limited exercise in COPD patients treated with tiotropium
Source: Eur Respir J 2004; 24: Suppl. 48, 214s
Year: 2004
New strategies to improve exercise capacity in COPD
Source: Annual Congress 2006 - MP1 – New strategies to improve exercise capacity in COPD
Year: 2006
Effects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPD
Source: Eur Respir J 2004; 23: 832-840
Year: 2004
Fat-free mass depletion and functional exercise capacity in COPD patients
Source: Annual Congress 2007 - Predicting factors of patients undergoing rehabilitation
Year: 2007
Dynamic hyperinflation and tolerance to interval exercise in patients with advanced COPD
Source: Eur Respir J 2004; 24: 385-390
Year: 2004
Comparing interval and continuous endurance training in COPD
Source: Annual Congress 2005 - Pulmonary rehabilitation: an evidence-based intervention
Year: 2005
Tiotropium improves walking endurance in COPD
Source: Eur Respir J 2012; 39: 265-271
Year: 2012
Changes of active expiration respiratory muscle (RM) in men with chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2011 - Respiratory and skeletal muscle assessment in health and disease
Year: 2011
Differences between walking and stair climbing in severe COPD patients receiving and not receiving long-term NIV
Source: Annual Congress 2007 - Physiological effects of noninvasive ventilation
Year: 2007
Respiratory muscle unloading improves peripheral muscle oxygenation during high-intensity, constant work rate exercise in patients with moderate to severe COPD
Source: Annual Congress 2007 - Exercise: respiratory muscle fatigue and dynamic hyperinflation
Year: 2007
Dose-response effect of oxygen on hyperinflation and exercise endurance in nonhypoxaemic COPD patients
Source: Eur Respir J 2001; 18: 77-84
Year: 2001
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept